nevro senza 1500 mri safety. You will first use the Trial Stimulator and Remote Control. nevro senza 1500 mri safety

 
You will first use the Trial Stimulator and Remote Controlnevro senza 1500 mri safety <samp> full market launch of its HFX iQ spinal cord stimulation (SCS) system, following the completion of a successful limited market</samp>

, mesh, sutures); it is not intended to anchor soft tissues to bone, nor repair cartilage, and is not intended for. 437): No Device labeled as "Not made with natural rubber latex": No For Single-Use: No Prescription Use (Rx): No Over the Counter (OTC):Nevro Headquarters Nevro Corp. AccessGUDID - Omnia (00813426020602)- No description. – The safety of program settings above 1,200 Hz have not been studied above the T8 vertebral level. It’s a small device, placed in a same-day, outpatient procedure, that safely works inside your body to significantly reduce your pain and restore your quality of life. **Throughout this presentation HFX TM for PDN means that a patient has been implanted with a Senza System and programmed to include a frequency of 10 kHz. What MRI safety information does the labeling contain?. 5 Tesla and 3 Tesla Magnetic Resonance Imaging (MRI) Guidelines for Senza® HFX iQTM System. 2, max. Sources. Scanning under diffe rent conditions may result in severe injury,Increase Patient Freedom. MDSS GMBH Schiffgraben 41 D-30175 Hannover, Germany. Other Active Implanted Devices – The Senza and Senza II systems may interfere with other implantedREDWOOD CITY, Calif. Jude Medical. u pacienta se systémem Nevro Senza SCS. . Krishnan Chakravarthy serves as a consultant to Abbott, Medtronic, Bioness, SPR Therapeutics, Nalu Medical, Omnia Medical, and Saluda Medical; founder of Newrom. Bring your patient ID card and Remote Control to the MRI appointment. 9415 [email protected] Senza Spinal Cord Stimulation System Nevro Corporation, Strength 1. Nevro® hereby declares that the Senza® HFX iQTM System and Senza® HFXTM Trial System is in compliance with the essential requirements and other relevant provisions of the Radio Equipment Directive (2014/53/EU) and U. NEVRO CORP. Estas instruções só se aplicam ao sistema Senza e não a outros produtos. 650. The potential risks of performing MRI on patients with an implanted Senza system include: - Device movement - Excessive heating of or around the implanted device components - Tissue damage - Damage to the device - Uncomfortable sensation - Image artifact . Brand Name: Nevro® Version or Model: ACCK3050 Commercial Distribution Status: In Commercial Distribution Catalog Number: ACCK3050 Company Name: NEVRO. 1800 Bridge Parkway Redwood City, CA 94065 aus einem Senza®-Rückenmarkstimulationssystem und unterstützenden Dienstleistungen. National Hospital for Neurology and Neurosurgery at Cleveland Street. Medical technologies are continually changing and magnetic resonance imaging (MRI) is no exception, where increasing the magnet strength has produced more sophisticated device capabilities. Coding – Organized lists of CPT, ICD-10-CM, and relevant HCPCS codes. Sollten Sie Fragen oder Bedenken im Zusammenhang mit Produkten von Nevro haben, wenden Sie sich bitte anhand folgender Kontaktdaten an: Nevro Corp . Allows for the delivery of 2-1200 Hz & 10,000 Hz frequencies in. . . . Device Name: Senza Omnia IPG Kit . MRI . Royal London Hospital for Integrated Medicine. The second lead was introduced with difficulty. (NYSE: NVRO ), a global medical deviceNevro, a company based in Menlo Park, California, won FDA approval for its Senza spinal cord stimulation system. The Senza System has a very similar safety profile to other SCS devices that have been available for many years. 000 Hz und eine Kombination aus diesen abzudecken. . Risks Associated with MRI with Senza System. What is Nevro HFX? HFX is a nondrug, FDA-approved treatment option for long-term chronic pain relief. Global Unique Device ID: 00813426020510. . The Senza System has a very similar safety profile to other SCS devices that have been available for many years. Also, please discuss. Full body conditional MRI labeling; Upgradable to future waveforms and frequencies; Omnia Clinician Programmer. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Senza spinal cord stimulation (SCS). . 251. . 0005 Fax: +1. *HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain. The Senza SCS System is shown in Figure 1 below:AccessGUDID - Senza® (00813426020121)- Senza® Charger Kit . . NIH Device Record Key. 0 T MRI, as both were used to identify nine tumours, metastatic infiltration in 16 patients, and fibre thickening in two patients (nerve tumours and brachial. A patient with Stryker Detachable Coils can be safely scanned immediately after placement of the coils, under the following conditions: Static magnetic field of 1. DRAFT Physician Implant Manual SenzaÂŽ Senza IIâ ˘ ONLY NEVRO CORP. studies of the Senza System and safety and effectiveness data. Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Risks Associated with MRI with Senza System . During the trial of the Senza System, a thin flexible wire (stimulator lead) is typically placed through a needle. Nevro's SENZA-NSRBP study compares Nevro's proprietary high-frequency (10 kHz) SCS plus CMM to CMM alone in 159 randomized patients at 15 study centers. 251. . 650. Typically safer than other spine surgeries used to address chronic pain 1-5. The Senza, Senza II, Senza Omnia, and HFX iQ neuromodulation systems, when programmed to include a frequency of 10 kHz, are indicated as aids in the management of non-surgical refractory back pain (intractable back pain without prior surgery and not a candidate for back surgery). Nevro IPG(s) NIPG1000, NIPG1500, NIPG2000, NIPG2500 Nevro Percutaneous Leads LEAD10x8-xxB: LEAD1058-50B,. IMPORTANT: Do not change or modify any component of the Senza ® TMHFX iQ System and Senza ®. 1800 Bridge Parkway Redwood City, CA 94065 U. S. They should only be exposed to MRI under conditions outlined in the instructions for use and the full-body MRI conditional label issued in November 2017. You will first go through a trial phase where you and your doctor evaluate the therapy to see if its right for you. g. Contraindications An assembly of devices that applies an electrical stimulus to all or part of the spinal cord to relieve pain (analgesia). Farrukh Ansari. Please note that product literature varies by geography. Magnetic Resonance Imaging (MRI) - The Senza system is MR. Dear Nevro Physician, Background: Nevro has recently become aware that a relatively small number of patients who have been implanted with a Nevro Senza SCS System and received an S8 Lead Adaptor SADP2008-xx(B) or M8 Lead Adaptor MADP2008-xx(B)Patient Manual Patient Manual 11052 Rev A (2015-01-16) 1 NEVRO CORP. e. Displaying 1 - 1 of 1. Medtronic, Inc. Tel. NIH Device Record Key. . Patient Manuals and MRI Guidelines. Object Status Conditional 5. Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. April 30th, 2021 . HFX permits full body MRI scanning under certain conditions. The potential risks of performing MRI on patients with an implanted Senza system include: - Device movement - Excessive heating of or around the implanted device components - Tissue damage - Damage to the device - Uncomfortable sensation - Image artifact . 1800 Bridge Parkway . 7. 1 Doctor Visit Discussion Guide Email or print this guide now and bring it to your next appointment. Nevro patient satisfaction. ) are receive only. Nevro recommends reviewing commercial contracts and medical policies to determine if it is appropriate to bill certain HCPCS codes described herein. • Fail to receive effective pain relief during trial stimulation. FCC CFR 47 Part 15. . Company Name: NEVRO CORP. Appendix: SENZA System MRI Scan Checklist This checklist is provided as an optional resource to support MR centers in conducting and MRI of a patient implanted with the Nevro SENZA system. , March 22, 2018 /PRNewswire/ -- Nevro Corp. 1800 Bridge Parkway Redwood City, CA 94065, USA Tel: +1. 251. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that full-body magnetic resonance imaging (MRI) conditional labeling is now available in the United States for. Nevro Senza Spinal Cord Stimulation System. 1800 Bridge Parkway Redwood City, CA 94065 U. . 1800 Bridge Parkway Redwood City, CA 94065 USA 1. g. Nevro Corp. 5T or 3T horizontal bore MRIMeaningful Evidence To Support Your Practice. 00813426020602. Nevro's proprietary 10 kHz Therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies. means that safety has been demonstrated only within specifically defined . Refer to Senza MRI Guidelines for detailed information on MRI safety and conditions. The Omnia system is. The Senza neuromodulation system is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain, and leg pain. Version (Model) Number: NIPG1500. During the trial of the Senza System, a thin flexible wire (stimulator lead) is typically placed through a needle. is under license. 5-T and 3-T. THE List. . 5T and 3T MRI . . I just met with my rep, sat close to her and her computer and she read the impedance on all 16. erfolgt unter Lizenz. o: LEAD2008-xxB), âncoras de elétrodos (Modelo n. All questions or concerns about Nevro products should be forwarded to: Nevro Corp. 4040 Campbell Avenue, Suite 210 Menlo Park, CA 94025, USA . 5 T MRI and with 3. Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. . Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. 2. Nevro has developed and commercialized the Senza. It is implanted under the skin and has an inbuilt battery. A. NEVRO ON-LABEL DIRECT CONNECTION Connect compatible Nevro leads directly to any Boston Scientific IPG: The Boston Scientific Direct Connection is compatible with the following Nevro leads and lead extensions: Blue Lead Extension Kit Model LEAD2008. TM. g. Furthermore, it is not intended to increase or maximize reimbursement by any payer. The potential risks of performing MRI on patients with an implanted Senza system include: - Device movement - Excessive heating of or around the implanted device components - Tissue damage - Damage to the device - Uncomfortable sensation - Image artifact . An electrically-insulated wire with a distal electrode intended to be implanted into the epidural space of the spinal cord and/or in/near a peripheral nerve (e. The IPG is. D. Kapural L, et al. Purpose To describe an MRI (1. IMPORTANT: Do not change or modify any component of the Senza HFX iQTM System and Senza HFXTM At the time of your procedure, your doctor will provide your specific recovery instructions and it’s important to follow them closely. Bring your patient ID card and Remote Control to the MRI appointment. Refer to Senza MRI Guidelines for detailed information on MRI safety and conditions. Stimulation at vertebral levels above T8 â Safety of Nevro SCS system at >2kHz to10 kHz program settings above the T8 vertebral level has not been studied. 5. 2007;188(5):1388–94. Risks Associated with MRI with Senza System . Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of. It includes an implanted lead/electrode system located in the epidural space of the spinal cord attached to either an implanted passive electronic circuit into which signals and/or energy is inductively coupled from outside the body, or to a totally implantable self. Photo: courtesy of Nevro Corp. , lumbar, truncal, in a limb) via. Check with the manufacturer for the most recent updates. . AccessGUDID - Omnia (00813426020572)- Senza Omnia IPG Kit An electrically-powered, implantable component of a spinal cord/peripheral nerve implantable analgesic electrical stimulation system intended to deliver electrical impulses to the epidural space of the spinal cord and/or in/near a peripheral nerve (e. S. To learn more about filing a spinal-cord stimulator implant lawsuit, please call (888) 994-5118. 04 Feb, 2015, 04:01 ET. Nevro Corp. . Full Body MRI7 All Nevro systems are conditionally approved for full body MRI scans. and our belief that the safety and efficacy data from the SENZA-NSRBP RCT will be used to support increased patient access and. The implanted components of the Senza system may include Nevro percutaneous leads (LEAD10x8-xx(B)), lead extensions (LEAD2008-xx(B)), lead anchors (ACCK5xxx), IPG port plug (ACCK7000), and the Senza implantable pulse generator (NIPG1000 or NIPG1500). Nevro Headquarters. More . 7: Sep 13, 2022: Treatment of Congestive Heart Failure With Electrical Stimulation, and Associated Systems and MethodsSafety Topic/Article: The implanted Senza Spinal Cord Stimulation (SCS) System (Nevro Corporation) is MR Conditional and has been demonstrated to present no known hazards in a specified MRI environment when following specific guidelines as described in the 1. Medical device firm Nevro has secured approval from the US Food and Drug Administration (FDA) for its Senza Omnia spinal cord stimulation (SCS) system to treat chronic. Appendix: SENZA System MRI Scan Checklist This checklist is provided as an optional resource to support MR centers in conducting and MRI of a patient implanted with the Nevro SENZA system. Risks Associated with MRI with SENZA System . ContraindicationsSenza is the First Implantable Spinal Cord Stimulator System that is 3 Tesla MRI Compatible Nevro Corp. 251. In Commercial Distribution. Full Body MRI7 All Nevro systems are conditionally approved for full body MRI scans. SENZA®, SENZA II® and SENZA. You will first go through a trial phase where you and your doctor evaluate the therapy to see if its right for you. s28. Nevro Senza Spinal Cord Stimulation System Nevro Corporation, 1. 2. AI Usage . Risks Associated with MRI with Senza System . Safety Info ID#. comNevro, a firm based in Silicon Valley, won FDA approval for its Senza Omnia spinal cord neurostimulation system for chronic pain management. UW Health Radiology Guidelines for MRI in Patients with Common Complex Devices:. For United States of America. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that full-body magnetic resonance imaging (MRI) conditional labeling is now. This includes one-sided or two-sided pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. V. email, or text message communications about Nevro and other health information. It is important to read this full document prior to conducting or recommending an MRI examination on a patient with the Senza system. de modèle : ACCK5xxx), une prise IPG (ACCK7000) et le générateur d'impulsions implantable Senza (n. Food and Drug Administration (FDA) for the Senza ® Omnia ™ Spinal Cord Stimulation (SCS) System. Paresthesia-Free with HF10®1,2 With HF10® programs (stimulation at 10,000 Hz),. 251. und jede Nutzung dieser Marken durch die Nevro Corp. É importante ler todo este documento antes de efectuar ou de recomendar um exame de MRI a um doente com o sistema SCS Nevro Senza. 1800 Bridge Parkway. , Nevro. Strong interference, such as from a defibrillator or MRI (if the spinal cord stimulation device is not MRI-safe), can damage the generator, leading to severe burns, other serious injury, or death. The following are some warnings for the Senza system: The authors noted that pathologic findings were equal with 1. 4040 Campbell Avenue, Suite 210 Menlo Park, CA 94025 USA Tel: +1. 0T machines or vertical field orientation machines, as device damage, excessive heating of implanted components, and serious patient injury could occur. Effective November 2022. Table of Contents INTRODUCTION. 0005 . Contraindications Full body conditional MRI labeling; Upgradable to future waveforms and frequencies; Omnia Clinician Programmer. The potential risks of performing MRI on patients with an implanted Senza system include: - Device movement - Excessive heating of or around the implanted device components - Tissue damage - Damage to the device - Uncomfortable sensation - Image artifact . (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received CE Mark for full-body magnetic resonance imaging (MRI) conditional. Nevro's battery is designed to last 10+ years at all common programming settings. Nevro (n. . Use only product literature from the region where the patient procedure was performed. 11096 Rev J MRI Procedure Information For Abbott Medical MR Conditional Neurostimulation Systems. 5 Risks Associated with MRI with Senza System. 5 Tesla and 3 Tesla Magnetic Resonance Imaging (MRI) Guidelines for the Senza System orws4k@ I forgot to mention that it's important to know about whether you can get an MRI with a device you get. Nevro Corporation, Risks Associated with MRI with Senza System . You can We would like to show you a description here but the site won’t allow us. Brand Name: Omnia. g. 7 million in Q1 2015, up 70% at constant currencies. p: +1-650-251-0005. The safety of HFX has been thoroughly studied and proven. MR Unsafe:The implanted components of the Senza system may include Nevro percutaneous leads (LEAD10x8-xx(B)), lead extensions (LEAD2008-xx(B)), lead anchors (ACCK5xxx), IPG port plug (ACCK7000), and the Senza implantable pulse generator (NIPG1000 or NIPG1500). Every person is unique and your medical needs differ from those of others, even people with the same. Reported issues include infections, sepsis, shocking sensations, and numbness. Nevro Corp. 1800 Bridge Parkway . Indications for Use: The Senza®, Senza II™ and Senza Omnia™ neuromodulation systems are used as aids in the management of chronic intractable pain of the trunk and/or limbs. Your MRI Tech will confirm the results before your MRI. Risks Associated with MRI with Senza System . Quick, outpatient & minimally invasive. -based. The Senza, Senza II, and Senza Omnia Systems should not be used for those patients who: • Are poor surgical candidates, including those with poor glycemic control in whom the safety of the device has not yet been characterized, i. 1. ARTEN600090483 AMENLO PARK, Calif. More. Talk to your doctor about complications related to the procedure and/or device, which include infection, swelling, bruising, undesirable changes in stimulation and loss of strength or use in an affected limb or muscle group (e. 5’ x 15. : +1. 3876 Nevro. Second, the need for protections of novel intellectual property makes. Medtronic Prima Advanced Surescan MRI: 2013: Nevro Senza: 2015: Nevro Senza II: 2018: Open in a separate window. 12. 00813426020572. Excerpts Pertaining to the Joint Commission’s (TJC) Revised Requirements for Diagnostic Imaging Services Related to MRI Safety: 1 Ellipse Implantable Cardioverter Defibrillator (ICD) System, St. Intuitive functionality to enhance the patient experience and improve ease. Pediatric Use - The safety and effectiveness of spinal cord stimulation has not been established for use in children. “Now I have an active lifestyle for the first time since I was in my 30s. NSRBP RCT. 5T and 3T imaging. Now Available, FDA-Approved, Artificial Intelligence-based HFX iQ™. to protect your safety. MRI uses a powerful static magnetic field, gradient magnetic fields, and RF energy to construct an image of a section of the body. Nevro Senza Spinal Cord Stimulator - MRI available. Fax: +1. You control the implanted device with the same Remote Control. Nevro, SENZA, SENZA II, Omnia, SENZA Omnia, Senza Bluetooth®, Surpass, Surpass-C, HF10 und das Nevro-Logo. inside the body (see IPG in the diagram above). You will first use the Trial Stimulator and Remote Control. Nevro's SENZA-PDN study, the largest RCT of spinal cord stimulation treatment conducted for PDN, compares 10 kHz SCS plus CMM to CMM alone in 216 patients at 18 centers in the United States. YOU ARE ABOUT TO EXIT FOR A WEBSITE INTENDED FOR THE RESIDENTS OF ANOTHER COUNTRY OR REGION. (3T has severe limitations. For Medicare claims, Nevro’s IPG kit and charger kit should billed under revenue code 278 with HCPCS C1822 (generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system). Nevro HFX. If you need support, please call: +1-844-331-1001. 12. 2. Lead, instead of connecting to an external stimulator as occurred during the trial phase, will. g. S. MR Conditional . 650. 1 ABOUT CHRONIC PAINYOU ARE ABOUT TO EXIT FOR A WEBSITE INTENDED FOR THE RESIDENTS OF ANOTHER COUNTRY OR REGION. Product Code Description HCPCS Code. Despite technical challenges, MRI is feasible, safe and diagnostically useful in HF-SCS-implanted patients. It is important to read the entire SENZA System MRI Guidelines manual (11096) prior to conducting an MRI scan. The device can deliver traditional spinal cord. AccessGUDID - Nevro® (00813426020251)- N300 Lead Anchor Kit. Spinal cord stimulation was approved by the U. , mesh, sutures); it is not intended to anchor soft tissues to bone, nor repair cartilage, and is not intended for ophthalmic use. Spinal Cord Stimulation System. , et al. Fax: +1. S. Nevro Receives CE Mark for Full-Body MRI Conditional Labeling with the Senza® Spinal Cord Stimulation System 11/15/2017 Expanding Patient Access to Nevro's HF10 Therapy through Broader Imaging Compatibility REDWOOD CITY, California , Nov. 15, 2017 /PRNewswire/ -- Nevro Corp. I understand these communications may include advertisements for goods and I can unsubscribe at any time. This includes one-sided or two-sided pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. , paralysis). S. Learn More about the Nevro SCS systems at #NevroHFX #ChronicPain. Conclusions. SENZA; NEVRO SENZA: Back to Search Results: Model Number NIPG2000: Device Problem Adverse Event Without Identified Device or Use Problem (2993). Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The safety of HFX has been thoroughly studied and proven. Neurostimulation System: Senza Spinal Cord Stimulation System Nevro Corporation. Footnotes *Within conditional parameters. Safety Topic / Subject Neurostimulation System: Senza Spinal Cord Stimulation System, Nevro Corporation. Find a Doctor. This afternoon. - Many. All questions or concerns about Nevro Corp. Brand Name. The Omnia system is the first and only. Noter que les éléments MR Conditional du système Senza . e-li mít dotazy, kontaktujte prosím společnost Nevro na adrese nebo telefonním čísle, které jsou uvedeny na konci tohoto dokumentu. . Primary Device ID. 15, 2017 /PRNewswire/ - Nevro Corp. Table of Contents INTRODUCTION. Nevro Corp. Nevro Corp. Bench-top tests have shown that patients implanted with the Senza system can be safely exposed to MR environments specified in this guideline. Stimulation between 1,200 Hz and 10,000 Hz has not been evaluated for safety, Patient Manual. The potential risks of performing MRI on patients with an implanted Senza system include: - Device movement - Excessive heating of or around the implanted device components - Tissue damage - Damage to the device - Uncomfortable sensation - Image artifact . Spectra WaveWriter Information for Prescribers Manual. - Patient consented and consent form to be signed by EP. MRI SAFETY INFORMATION The Axonics SNM System is an MR Conditional device. Minimal restrictions and reversible. ne. Version (Model) Number: NIPG1500. Pediatric Use - The safety and effectiveness of spinal cord stimulation has not been established for use in children. It indicates a way to close an interaction, or dismiss a notification. Nevro. Tel: +1. Senza HFX iQ is the first. Results will be presented at the 2023 North American. 5T cylindrical-bore magnet, horizontal field orientation MRI systems. Labeling does not contain MRI Safety Information Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801. os. g. . AccessGUDID - Nevro® (00813426020398)- Surgical Lead Kit, 50cm. IMPORTANT: Do not change or modify any component of the Senza ® HFX iQ. Senza MRI Guidelines; Senza Summary of Safety and Effectiveness Data (SSED). (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that two abstracts for Painful Diabetic Neuropathy (PDN) and Non-Surgical Back Pain (NSBP) were accepted for podium presentations at the 2023 North American. Objectives. Take Pam, for example. 1800 Bridge Parkway Redwood City, CA 94065 USA . 5 T MRI and with 3. HFX iQ is the only SCS system that uses Artificial. Senza HFX iQ™ uses a fixed set of instructions to provide optimized treatment recommendations that utilize direct patient input from assessments on pain and quality of life measures. You will first go through a trial phase where you and your doctor evaluate the therapy to see if its right for you. Quick, outpatient & minimally invasive. The Senza®, Senza II™ and Senza Omnia™Senza is the First Implantable Spinal Cord Stimulator System that is 3 Tesla MRI Compatible Nevro Corp. The Senza syste m components will include: Implantable pulse generator (IPG) is a small, battery-powered electronic device that is implanted. . The Senza System has a very similar safety profile to other SCS devices that have been available for many years. The patient had a prior laminectomy. AccessGUDID - Nevro (00813426020510)- Senza II. . FCC CFR 47 Part 15.